Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma

Por Kazmi, SMA, Saliba, RM, Donato, M, Wang, M, Hosing, C, Qureshi, S, Anderlini, P, Popat, U, Champlin, RE, Giralt, SA, Qazilbash, MH
Publicado em 2010